Literature DB >> 11001063

Peptide cyclization catalysed by the thioesterase domain of tyrocidine synthetase.

J W Trauger1, R M Kohli, H D Mootz, M A Marahiel, C T Walsh.   

Abstract

In the biosynthesis of many macrocyclic natural products by multidomain megasynthases, a carboxy-terminal thioesterase (TE) domain is involved in cyclization and product release; however, it has not been determined whether TE domains can catalyse macrocyclization (and elongation in the case of symmetric cyclic peptides) independently of upstream domains. The inability to decouple the TE cyclization step from earlier chain assembly steps has precluded determination of TE substrate specificity, which is important for the engineered biosynthesis of new compounds. Here we report that the excised TE domain from tyrocidine synthetase efficiently catalyses cyclization of a decapeptide-thioester to form the antibiotic tyrocidine A, and can catalyse pentapeptide-thioester dimerization followed by cyclization to form the antibiotic gramicidin S. By systematically varying the decapeptide-thioester substrate and comparing cyclization rates, we also show that only two residues (one near each end of the decapeptide) are critical for cyclization. This specificity profile indicates that the tyrocidine synthetase TE, and by analogy many other TE domains, will be able to cyclize and release a broad range of new substrates and products produced by engineered enzymatic assembly lines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11001063     DOI: 10.1038/35025116

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  62 in total

Review 1.  Genetics and assembly line enzymology of siderophore biosynthesis in bacteria.

Authors:  Jorge H Crosa; Christopher T Walsh
Journal:  Microbiol Mol Biol Rev       Date:  2002-06       Impact factor: 11.056

2.  Regeneration of misprimed nonribosomal peptide synthetases by type II thioesterases.

Authors:  Dirk Schwarzer; Henning D Mootz; Uwe Linne; Mohamed A Marahiel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-16       Impact factor: 11.205

Review 3.  Learning from nature's drug factories: nonribosomal synthesis of macrocyclic peptides.

Authors:  Stephan A Sieber; Mohamed A Marahiel
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

4.  Cyclization of synthetic seco-proansamitocins to ansamitocin macrolactams by Actinosynnema pretiosum as biocatalyst.

Authors:  Kirsten Harmrolfs; Marco Brünjes; Gerald Dräger; Heinz G Floss; Florenz Sasse; Florian Taft; Andreas Kirschning
Journal:  Chembiochem       Date:  2010-12-10       Impact factor: 3.164

5.  Activity screening of carrier domains within nonribosomal peptide synthetases using complex substrate mixtures and large molecule mass spectrometry.

Authors:  Pieter C Dorrestein; Jonathan Blackhall; Paul D Straight; Michael A Fischbach; Sylvie Garneau-Tsodikova; Daniel J Edwards; Shaun McLaughlin; Myat Lin; William H Gerwick; Roberto Kolter; Christopher T Walsh; Neil L Kelleher
Journal:  Biochemistry       Date:  2006-02-14       Impact factor: 3.162

Review 6.  Nonribosomal peptide synthetases involved in the production of medically relevant natural products.

Authors:  Elizabeth A Felnagle; Emily E Jackson; Yolande A Chan; Angela M Podevels; Andrew D Berti; Matthew D McMahon; Michael G Thomas
Journal:  Mol Pharm       Date:  2008-01-25       Impact factor: 4.939

7.  Development of Tyrocidine A analogues with improved antibacterial activity.

Authors:  Michael A Marques; Diane M Citron; Clay C Wang
Journal:  Bioorg Med Chem       Date:  2007-08-11       Impact factor: 3.641

Review 8.  Nonproteinogenic amino acid building blocks for nonribosomal peptide and hybrid polyketide scaffolds.

Authors:  Christopher T Walsh; Robert V O'Brien; Chaitan Khosla
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-31       Impact factor: 15.336

9.  The thioesterase domain from a nonribosomal peptide synthetase as a cyclization catalyst for integrin binding peptides.

Authors:  Rahul M Kohli; Junichi Takagi; Christopher T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

10.  Escherichia coli allows efficient modular incorporation of newly isolated quinomycin biosynthetic enzyme into echinomycin biosynthetic pathway for rational design and synthesis of potent antibiotic unnatural natural product.

Authors:  Kenji Watanabe; Kinya Hotta; Mino Nakaya; Alex P Praseuth; Clay C C Wang; Daiki Inada; Kosaku Takahashi; Eri Fukushi; Hiroki Oguri; Hideaki Oikawa
Journal:  J Am Chem Soc       Date:  2009-07-08       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.